Utility of time of onset of hypertension, ADMA and TAS in predicting adverse neonatal outcome in hypertensive disorders of pregnancy

References

• Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol. 2013;25:124–132. doi:10.1097/GCO.0b013e32835e0ef5.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Ngoc NTN, Merialdi M, Abdel-Aleem H, Carroli G, Purwar M, Zavaleta N, Campódonico L, Ali MM, Hofmeyr GJ, Mathai M, et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ. 2006;84:699–705.
   PubMed Web of Science ®Google Scholar
• Hodgins S. Pre-eclampsia as underlying cause for perinatal deaths: time for action. Glob Health Sci Pract. 2015;3:525. doi:10.9745/GHSP-D-15-00350.
   PubMed Web of Science ®Google Scholar
• Kinney MV, Lawn JE, Howson CP, Belizan J. 15 Million preterm births annually: what has changed this year? Reprod Health. 2012;9:28. doi:10.1186/1742-4755-9-28.
   PubMed Web of Science ®Google Scholar
• Seyom E, Abera M, Tesfaye M, Fentahun N. Maternal and fetal outcome of pregnancy related hypertension in Mettu Karl Referral Hospital, Ethiopia. J Ovarian Res. 2015;8:10.
   PubMed Web of Science ®Google Scholar
• Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol. 2014;5:372.
   PubMed Web of Science ®Google Scholar
• Sydow K, Münzel T. ADMA and oxidative stress. Atheroscler Suppl. 2003;4:41–51.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Kampoli A-M, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10:4–18.
   PubMed Web of Science ®Google Scholar
• Huang L-T, Hsieh C-S, Chang K-A, Tain YL. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. Int J Mol Sci. 2012;13:14606–14622. doi:10.3390/ijms131114606.
   PubMed Web of Science ®Google Scholar
• Németh B, Murányi E, Hegyi P, Mátrai P, Szakács Z, Varjú P, Hamvas S, Tinusz B, Budán F, Czimmer J, et al. Asymmetric dimethylarginine levels in preeclampsia – systematic review and meta-analysis. Placenta. 2018;69:57–63. doi:10.1016/j.placenta.2018.07.010.
   PubMed Web of Science ®Google Scholar
• Alpoim PN, Godoi LC, Freitas LG, Gomes KB, Dusse LM. Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia. Nitric Oxide Biol Chem. 2013;33:81–82. doi:10.1016/j.niox.2013.07.006.
   PubMed Web of Science ®Google Scholar
• Laskowska M, Laskowska K, Terbosh M, Oleszczuk J. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sci Monit. 2013;19:430–437.
   PubMed Web of Science ®Google Scholar
• Bharadwaj S, Bhat VB, Vickneswaran V, Adhisivam B, Zachariah B, Habeebullah S. Oxidative stress in preeclamptic mother – newborn dyads and its correlation with early neonatal outcome – a case control study. J Matern Fetal Neonatal Med. 2018;31:1548–1553. doi:10.1080/14767058.2017.1319933.
   PubMed Web of Science ®Google Scholar
• Karacay O, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalvaç S, Akyol M, Kandemir O, Altan N. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation. Diabetes Res Clin Pract. 2010;89:231–238.
   PubMed Web of Science ®Google Scholar
• Eleuterio NM, Palei ACT, Machado JSR, Tanus-Santos JE, Cavalli RC, Sandrim VC. Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy. Blood Press. 2016;25:241–243. doi:10.3109/08037051.2015.1134550.
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Jaleel A, Al’Kadri HMF, Akram S, Tamimi W. Biomarkers of oxidative stress in women with pre-eclampsia. Biomark Med. 2013;7:229–234. doi:10.2217/bmm.12.109.
   PubMed Web of Science ®Google Scholar
• Oztas E, Ozler S, Tokmak A, Erel O, Ergin M, Uygur D, Danisman N. Oxidative stress markers in severe preeclampsia and preeclampsia-related perinatal morbidity – preliminary report. Ginekol Pol. 2016;87:436–441. doi:10.5603/GP.2016.0022.
   PubMed Web of Science ®Google Scholar
• Alpoim PN, Perucci LO, Godoi LC, Sahin Gunes E. Oxidative stress markers and thrombomodulin plasma levels in women with early and late severe preeclampsia. Clin Chim Acta Int J Clin Chem. 2018;483:234–238. doi:10.1016/j.cca.2018.04.039.
   PubMed Web of Science ®Google Scholar
• Gumus E, Atalay MA, Cetinkaya Demir B, et al. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia. J Matern Fetal Neonatal Med. 2016;29:3806–3811. doi:10.3109/14767058.2016.1147551.
   PubMed Web of Science ®Google Scholar
• Tsikas D, Bollenbach A, Savvidou MD. Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction? Amino Acids. 2018;50:341–351. doi:10.1007/s00726-017-2522-2.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143–148. doi:10.1081/PRG-120021060.
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239:70–76. doi:10.1006/abio.1996.0292.
   PubMed Web of Science ®Google Scholar
• Kandraju H, Agrawal S, Geetha K, Sujatha L, Subramanian S, Murki S. Gestational age-specific centile charts for anthropometry at birth for South Indian infants. Indian Pediatr. 2012;49:199–202. doi:10.1007/s13312-012-0060-2.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, Kinney M, Lawn J; Born Too Soon Preterm Birth Action Group. Born too soon: The global epidemiology of 15 million preterm births. Reprod Health. 2013;10:S2. doi:10.1186/1742-4755-10-S1-S2.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet Lond Engl. 2012;379:2162–2172. doi:10.1016/S0140-6736(12)60820-4.
   PubMed Web of Science ®Google Scholar
• Esch JJA, Heijst AF van de Haan AFJ, van der Heijden OWH. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. J Matern Fetal Neonatal Med. 2017;30:2789–2794.
   PubMed Web of Science ®Google Scholar
• Uzan J, Carbonnel M, Piconne O, Ayoubi J-M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467–474.
   PubMedGoogle Scholar
• Krause BJ, Hanson MA, Casanello P. Role of nitric oxide in placental vascular development and function. Placenta. 2011;32:797–805. doi:10.1016/j.placenta.2011.06.025.
   PubMed Web of Science ®Google Scholar
• Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun. 1999;263:681–684. doi:10.1006/bbrc.1999.1422.
   PubMed Web of Science ®Google Scholar
• Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial Regulation of Vasomotion in ApoE-Deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:1282–1288.
   PubMed Web of Science ®Google Scholar
• Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20:2032–2037. doi:10.1161/01.ATV.20.9.2032.
   PubMed Web of Science ®Google Scholar
• Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19:E1496.
   PubMed Web of Science ®Google Scholar
• Genc H, Uzun H, Benian A, Simsek G, Gelisgen R, Madazli R, Güralp O. Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk. Arch Gynecol Obstet. 2011;284:1367–1373. doi:10.1007/s00404-011-1865-2.
   PubMed Web of Science ®Google Scholar
• D’Souza V, Rani A, Patil V, Pisal H, Randhir K, Mehendale S, Wagh G, Gupte S, Joshi S. Increased oxidative stress from early pregnancy in women who develop preeclampsia. Clin Exp Hypertens. 2016;38:225–232.
   PubMed Web of Science ®Google Scholar
• Gohil JT, Patel PK, Gupta P. Evaluation of oxidative stress and antioxidant defence in subjects of preeclampsia. J Obstet Gynaecol India. 2011;61:638–640. doi:10.1007/s13224-011-0094-8.
   PubMedGoogle Scholar
• Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1998;178:551–556.
   PubMed Web of Science ®Google Scholar
• Rizos D, Eleftheriades M, Batakis E, Rizou M, Haliassos A, Hassiakos D, Botsis D. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby. J Matern Fetal Neonatal Med. 2012;25:1311–1315.
   PubMed Web of Science ®Google Scholar
• Bassi R, Sharma S, Mehta K, et al. Study of serum superoxide dismutase and malondialdehyde levels during normal pregnancy, 5.
   Google Scholar
• Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol. 2002;57:609–613.
   PubMed Web of Science ®Google Scholar
• Hung T-H, Lo L-M, Chiu T-H, Li MJ, Yeh YL, Chen SF, Hsieh TT. A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reprod Sci. 2010;17:401–409. doi:10.1177/1933719109359704.
   PubMed Web of Science ®Google Scholar
• Ueki N, Takeda S, Koya D, Kanasaki K. The relevance of the renin-angiotensin system in the development of drugs to combat preeclampsia. Int J Endocrinol. 2015;2015:572713. doi:10.1155/2015/572713.
   PubMed Web of Science ®Google Scholar
• De Ocampo MPG, Araneta MRG, Macera CA, Alcaraz JE, Moore TR, Chambers CD. Folic acid supplement use and the risk of gestational hypertension and preeclampsia. Women Birth J Aust Coll Midwives. 2018;31:e77–e83. doi:10.1016/j.wombi.2017.08.128.
   PubMed Web of Science ®Google Scholar
• Manizheh SM, Mandana S, Hassan A, Amir GH, Mahlisha KS, Morteza G. Comparison study on the effect of prenatal administration of high dose and low dose folic acid. Saudi Med J. 2009;30:88–97.
   PubMed Web of Science ®Google Scholar
• Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women [Internet]. Geneva: World Health Organization; 2012 [cited 2018 Nov 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK132263/.
   Google Scholar
• From the Centers for Disease Control and Prevention. Recommendations for use of folic acid to reduce number of spina bifida cases and other neural tube defects. JAMA. 1993;269:1233, 1236–1238.
   PubMed Web of Science ®Google Scholar